.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Indian government recently announced a significant Customs Duty Exemption on 40 petrochemical inputs. This measure aims to protect the pharmaceutical and medical technology sectors from rising costs. These industries currently face immense pressure due to the ongoing conflict in West Asia. Consequently, the Finance Ministry released a comprehensive list of products eligible for this temporary relief. This policy remains effective until June 30 to ensure the steady supply of essential medical goods.
Industry leaders have welcomed this proactive step to stabilize the domestic healthcare market. The Indian Pharmaceutical Alliance (IPA) noted that the conflict disrupts the timely movement of products. Specifically, raw materials like Polypropylene, ABS, and PVC resin are vital for medical consumables. Previously, input prices surged by up to 50 percent because of freight hikes and supply shortages. Therefore, the Customs Duty Exemption directly addresses these inflationary pressures. Manufacturers expect this move to lower production costs for critical items like MRI scanners and low-risk consumables.
Besides immediate tax relief, the industry seeks long-term structural changes. For instance, medical device makers have requested lower GST rates on raw materials. Currently, many APIs and reagents attract an 18 percent GST rate. Reducing this to 5 percent could further boost the global competitiveness of Indian goods. Furthermore, the IPA suggested forming an 'Empowered Committee of Secretaries' for better coordination. These steps would help maintain an uninterrupted supply of critical healthcare products during global volatility.
Q1: Why did the government announce this duty exemption?
The government introduced the measure to offset rising costs and supply chain disruptions caused by the conflict in West Asia, which impacted petrochemical feedstocks used in medicine production.
Q2: Which materials are included in the exemption list?
The exemption covers 40 petrochemical inputs, including Polypropylene, ABS, Polycarbonate, and PVC resin, which are essential for manufacturing medical consumables and devices.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Centre has exempted 40 petrochemical inputs from customs duty until June 30 to help pharma and medtech manufacturers manage rising costs from global con...
6 months ago
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today
In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
